Home ›
Trademark Categories ›
Pharmaceuticals ›
1999 ›
AN ›
ANZARE
Trademark search for:
ANZARE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
1999-11-10 — Application filed
2000-03-09 — Assigned to examiner
2000-03-13 — Assigned to examiner
2000-03-27 — Final disposition recorded
2000-08-02 — Correspondence received in law office
2000-10-16 — Approved for pub - principal register
2001-03-14 — Notice of publication
2001-03-27 — Published for opposition
2001-06-19 — Noa mailed - sou required from applicant
2001-09-25 — Sou extension 1 filed
2001-10-05 — Sou extension 1 granted
2002-04-25 — Sou teas extension received
2002-04-26 — Sou extension 2 filed
2002-05-06 — Sou extension 2 granted
2002-10-18 — Sou teas extension received
2002-10-18 — Sou extension 3 filed
2002-10-21 — Paper received
2002-11-07 — Sou extension 3 granted
2003-01-09 — Assigned to examiner
2003-05-07 — Sou teas extension received
2003-05-08 — Sou teas extension received
2003-05-08 — Sou extension 4 filed
2003-06-05 — Sou extension 4 granted
2003-11-13 — Sou teas extension received
2003-11-13 — Sou extension 5 filed
2003-11-25 — Sou extension 5 granted
2004-06-20 — Final status recorded
2004-06-29 — Case file in ticrs
2004-08-16 — Application abandoned
Owner Information
BRISTOL-MYERS SQUIBB COMPANY
New York , NY
BRISTOL-MYERS SQUIBB COMPANY
New York , NY
Correspondent
NADINE P FLYNN BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVE NEW YORK, NY 10154 UNITED STATES
Filing Details
Filing Date:
1999-11-10
Status Date:
2004-06-20
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.